Cellular membranes and intracellular macromolecules

Cellular membranes and intracellular macromolecules represent the fundamental structural and functional building blocks of the cell, including lipid bilayers, nucleic acids, and proteins [1][3]. In a pharmacological context, these are categorized as broad targets for drugs that exert their effects through non-specific chemical or physical interactions rather than binding to a single defined molecular pocket [4]. For instance, alkylating agents like cisplatin target intracellular DNA to induce cross-linking and apoptosis in rapidly dividing cancer cells [1][5]. Similarly, certain antibiotics and antifungals, such as amphotericin B, target the integrity of cellular membranes to cause lethal ion leakage in pathogens [2]. Because these targets are ubiquitous across various cell types, drugs acting on them often face significant challenges regarding selectivity and systemic toxicity [1]. Intracellular macromolecules also include the protein synthesis machinery and structural filaments, which are targeted by agents like vinca alkaloids or macrolides [4]. Despite their importance, this target designation is often considered too broad for modern precision medicine, which favors specific molecular entities [4]. Monitoring the effects on these targets often involves measuring non-specific markers of damage, such as DNA adducts or membrane permeability changes [5]. Overall, while historically significant, these targets represent a diverse group of substrates rather than a single therapeutic target [4].

Other names

Biological membranesIntracellular substratesCellular componentsCytoplasmic macromolecules

Drugs targeting these structures act through non-specific chemical or physical mechanisms, such as DNA alkylation, intercalation between nucleic acid bases, or the disruption of lipid bilayer permeability and integrity [1][2][5].